Search by Drug Name or NDC

    NDC 28595-0809-30 HISTEX PD Drops New Formulation 1.25 mg/mL Details

    HISTEX PD Drops New Formulation 1.25 mg/mL

    HISTEX PD Drops New Formulation is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Allegis Pharmaceuticals, LLC. The primary component is TRIPROLIDINE HYDROCHLORIDE.

    Product Information

    NDC 28595-0809
    Product ID 28595-809_0d08439b-3e83-1798-e063-6394a90a1f52
    Associated GPIs
    GCN Sequence Number 077542
    GCN Sequence Number Description triprolidine HCl DROPS 1.25 MG/ML ORAL
    HIC3 Z2P
    HIC3 Description ANTIHISTAMINES - 1ST GENERATION
    GCN 43586
    HICL Sequence Number 004508
    HICL Sequence Number Description TRIPROLIDINE HCL
    Brand/Generic Brand
    Proprietary Name HISTEX PD Drops New Formulation
    Proprietary Name Suffix n/a
    Non-Proprietary Name TRIPROLIDINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 1.25
    Active Ingredient Units mg/mL
    Substance Name TRIPROLIDINE HYDROCHLORIDE
    Labeler Name Allegis Pharmaceuticals, LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 28595-0809-30 (28595080930)

    NDC Package Code 28595-809-30
    Billing NDC 28595080930
    Package 1 BOTTLE in 1 CARTON (28595-809-30) / 30 mL in 1 BOTTLE
    Marketing Start Date 2023-12-13
    NDC Exclude Flag N
    Pricing Information N/A